
Humana Marketplace was the individual health insurance product line of Humana Inc. (NYSE: HUM), covering Affordable Care Act exchange plans. Humana announced in February 2017 that it would exit the individual commercial market, and it stopped offering marketplace plans effective 2018. Humana has not returned to the ACA marketplace and focuses its insurance business on Medicare Advantage, Medicaid, and employer group coverage.
| Brand | Parent Company | Ownership Type |
|---|---|---|
| Humana Marketplace (Discontinued) | Humana Inc. | Wholly owned |
Humana entered the Affordable Care Act marketplaces for the 2014 plan year, the first year exchanges opened, selling individual coverage in multiple states. Like many large insurers, it struggled with the individual market's economics: the risk pool skewed older and sicker than projected, risk corridor payments fell far short, and medical losses mounted.
In February 2017, Humana announced it would exit all individual commercial coverage, on- and off-exchange, effective January 1, 2018, citing an "unbalanced risk pool." The exit predated the later market stabilization that produced the 2021 enhanced-subsidy growth wave, meaning Humana missed the recovery that lifted Centene's Ambetter, Oscar Health, and others.
Humana has not re-entered the marketplace. Its individual-market presence today is limited to dental, vision, and supplemental products sold under the Humana Individual Plans umbrella, not comprehensive medical coverage.
What does Humana own?
Humana owns a portfolio of health insurance and healthcare service brands organized under the Humana master brand and the CenterWell service brand. The portfolio includes Humana Medicare (Medicare Advantage plans), Humana Medicaid (managed care in 13 states), Humana Marketplace (ACA exchange plans), Humana Pharmacy (prescription drug services), CenterWell (senior primary care clinics, pharmacy, and home health), Humana Group Plans (employer-sponsored specialty products), and Humana Individual Plans (individual and family coverage).
Is Humana publicly traded?
Yes. Humana Inc. trades on the New York Stock Exchange under ticker symbol HUM. The company has been publicly traded since its corporate restructuring in the 1990s and is a component of major healthcare sector indices. Its market capitalization fluctuates with earnings performance and Medicare Advantage policy developments.
Who founded Humana?
Humana was founded in 1961 by David A. Jones Sr. and Wendell Cherry in Louisville, Kentucky, originally as a nursing home company called Extendicare Inc. The company pivoted to hospital management in the 1970s and then to health insurance in 1993, when it spun off its hospital operations. Jones served as CEO for decades and remained chairman until his retirement.
Where is Humana headquartered?
Humana is headquartered in Louisville, Kentucky, USA. The company has maintained its headquarters in Louisville since its founding in 1961. Humana operates major offices and care delivery facilities across the United States to support its national Medicare Advantage and Medicaid operations.
How many brands does Humana own?
Humana owns 8 major brands and product lines across its health insurance and healthcare services portfolio. These include Humana Medicare, Humana Medicaid, Humana Marketplace, Humana Pharmacy, Humana Healthcare Services, CenterWell, Humana Group Plans, and Humana Individual Plans. The company uses a focused brand strategy rather than a broad multi-brand portfolio.
Who owns Humana?
Humana is publicly owned with shares trading on the NYSE under ticker HUM. Ownership is distributed among institutional investors, mutual funds, and individual shareholders. No single shareholder holds a controlling interest. Major institutional holders include Vanguard Group, BlackRock, and State Street Corporation. The company operates independently without any parent organization.
What is Humana's revenue?
Humana reported FY2025 revenue of $129.7 billion, up from $117.8 billion in FY2024. For FY2026, the company guided to total revenue of at least $160 billion. The Insurance segment generated $124.6 billion in FY2025 revenue, representing 96.3% of consolidated premiums and services revenue. The company's revenue is heavily concentrated in Medicare Advantage, which accounted for 82.6% of Insurance segment premiums in FY2025.
Is Humana involved in any legal proceedings?
Yes. Humana is appealing a federal court's October 2025 decision rejecting its challenge to CMS Star Ratings methodology. The company also faces an ongoing DOJ investigation into Medicare Advantage risk adjustment practices. Additionally, Humana is subject to routine litigation related to claim denials and coverage decisions, which is typical for large health insurers. The company discloses material legal matters in its SEC filings.
During its operation, the plans provided ACA-compliant coverage including essential health benefits. The exit was criticized by regulators and consumer advocates for reducing competition in counties where Humana was a major issuer, though similar exits by other carriers were common during the same period.
During its operation, Humana marketplace plans carried standard ACA metal-tier designations and participated in CMS quality rating programs. No brand-specific awards are associated with the discontinued line.
2017 Exit: The withdrawal from all individual commercial markets left coverage gaps in counties where Humana had been a major or sole issuer, part of the broader insurer-exit wave that prompted state and federal policy responses.
Risk Pool Debate: Humana's "unbalanced risk pool" rationale became a flashpoint in the debate over whether the ACA's risk adjustment and subsidy structure adequately supported insurers serving sicker populations.
Merger Context: The exit occurred during the period of the blocked Aetna-Humana merger (terminated February 2017), making the business restructuring part of a broader strategic reset.
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Centene | USA | 2014 | Market leader | United states | All-ages | |
| Cvs Health | United States | 1853 | Mass market | North america | All Genders | |
| Cigna | USA | 1982 | Mass market | United states | All Genders | |
| Centene | USA | 1993 | Market leader | United states | All-ages | |
| Centene | USA | 1977 | Mass market | United states | All-ages | |
| Cvs Health | USA (Aetna Medicare operations) | 2006 | Market leader | United states | Seniors-65-plus |
Healthcare PharmaceuticalsOwned by Centene Corporation
Centene Corporation's Affordable Care Act marketplace health insurance brand, launched in 2014 and serving 5.8 million members across 29 states as the largest individual-market issuer.
Healthcare PharmaceuticalsOwned by CVS Health Corporation
American managed care and health insurance company offering medical, dental, pharmacy, and behavioral health plans, operating as a subsidiary of CVS Health Corporation.
Healthcare PharmaceuticalsOwned by The Cigna Group
American health insurance brand providing medical coverage, health plans, and wellness services for individuals, families, and employers through The Cigna Group.
Healthcare PharmaceuticalsOwned by Centene Corporation
Centene Corporation's New York State health plan, founded in 1993 by the Catholic bishops of New York and acquired for $3.75 billion in July 2018, serving more than 2.4 million members.
Healthcare PharmaceuticalsOwned by Centene Corporation
Centene Corporation's California health plan brand, founded in 1977 and acquired for approximately $6.8 billion in 2016, serving about three million members through Medi-Cal, Medicare, marketplace, and commercial plans.
Healthcare PharmaceuticalsOwned by CVS Health Corporation
CVS Health's Medicare Part D prescription drug plan brand, launched in 2006 and marketed under Aetna Medicare, one of the largest standalone drug plan issuers in the United States.
Market Positioning: Humana Marketplace (Discontinued) competes with 6 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Looking for brands with different ownership structures? These similar brands are not owned by Humana Inc., giving you alternative choices that support different corporate structures.
Healthcare PharmaceuticalsOwned by Walgreens Boots Alliance
Boots is the UK's leading pharmacy-led health and beauty retailer, founded in 1849, now operating as The Boots Group under Sycamore Partners since August 2025.
Boots is privately owned, unlike Humana Marketplace (Discontinued) which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Walgreens Boots Alliance
Duane Reade is a New York City drugstore chain owned by Walgreen Co. under Sycamore Partners, operating approximately 90 stores across the five boroughs.
Duane Reade is privately owned, unlike Humana Marketplace (Discontinued) which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Chempro Chemists
Australian online pharmacy operated by Chempro Chemists from Molendinar, Queensland. Offers prescription medications, health products, and wellness items through digital platforms and mail-order delivery.
Pharmacy Direct is privately owned, unlike Humana Marketplace (Discontinued) which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by IBSA Institut Biochimique S.A.
IBSA Institut Biochimique SA's branded levothyroxine softgel capsule (Tirosint) and liquid solution (Tirosint-SOL), FDA approved for hypothyroidism, formulated without dyes, gluten, lactose, alcohol, or sugar, providing an excipient-free alternative to conventional levothyroxine tablets for patients with sensitivities or absorption issues.
Tirosint is privately owned, unlike Humana Marketplace (Discontinued) which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Walgreens Boots Alliance
Walgreens is the largest U.S. pharmacy retail brand, operating roughly 8,000 stores. It went private in August 2025 under Sycamore Partners as a standalone company.
Walgreens is privately owned, unlike Humana Marketplace (Discontinued) which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Bausch + Lomb Corporation
Global eye health company and contact lens manufacturer founded in 1853, known for ULTRA, Biotrue One Day, and INFUSE lens lines. Public on NYSE and TSX under BLCO.
Bausch + Lomb operates independently without a large parent corporation.
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.

Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.

Pfizer's respiratory syncytial virus (RSV) vaccine approved for older adults, maternal immunization to protect infants, and younger at-risk adults. Launched 2023.

Prescription isotretinoin brand developed by Roche and approved by the FDA in 1982 for severe nodular acne. Roche discontinued the brand name in the United States in 2009; the drug continues as Roaccutane in international markets.